Clinical Trial Update: Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating peptide receptor radiotargeted therapy for carcinoid heart disease and carcinoid syndrome/tumor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Heart Disease
• Carcinoid Syndrome
• Carcinoid Tumor

Snippet

Sponsor: King's College Hospital NHS Trust | Conditions: Carcinoid Heart Disease, Carcinoid Syndrome | Phase 2 | Status: UNKNOWN